cerca CERCA
Domenica 16 Gennaio 2022
Aggiornato: 18:55
Temi caldi


OrbusNeich® Announces China Approval for COMBO® Coronary Stent

HONG KONG, Sept. 23, 2020 /PRNewswire/ -- OrbusNeich Medical Co. Ltd. has announced that the National Medical Products Administration (NMPA) has granted market approval for the COMBO BIO-ENGINEERED SIROLIMUS ELUTING STENT in China. It is the first dual therapy stent to both accelerate endothelial coverage and control neointimal proliferation through the combination of the proven pro-healing technology with an abluminal sirolimus drug elution delivered from a biodegradable polymer that achieves fu...

ora in
Prima pagina
in Evidenza